Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Sodium valproate information hub
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
Appraisals - CR PAR & PAR
Appraisals - CR PAR & PAR
01/05/2024
Company response to Preliminary Recommendation: opicapone (Ongentys®) 5285
01/05/2024
Preliminary Recommendation: opicapone (Ongentys®) 5285
27/06/2023
Company Response to Preliminary Recommendation: emtricitabine/tenofovir alafenamide (Descovy®) 2566
27/06/2023
Preliminary Recommendation: emtricitabine/tenofovir alafenamide (Descovy®) 2566
06/04/2023
Company Response to Preliminary Recommendation: levodopa carbidopa entacapone (Lecigon) 4871
06/04/2023
Preliminary Recommendation: levodopa carbidopa entacapone (Lecigon) 4871
08/04/2022
Appraisal Report: cariprazine (Reagila) 5032
Follow AWTTC:
